Advanced Search

Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2008 December;56(6) > Minerva Cardioangiologica 2008 December;56(6):605-21

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases

Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752

Frequency: Bi-Monthly

ISSN 0026-4725

Online ISSN 1827-1618

 

Minerva Cardioangiologica 2008 December;56(6):605-21

    REVIEWS

Treatment strategies in atrial fibrillation

Wong K. C. K., Betts T. R.

Cardiac Rhythm Management Cardiology Department John Radcliffe Hospital, Headington, Oxford, UK

Atrial fibrillation (AF) is the most common cardiac arrhythmia in clinical practice affecting up to 1% of the general population. There is a higher prevalence and incidence with increasing age and burden of chronic heart disease . Treatment for AF represents a significant healthcare cost, estimated to be about € 13.5 billion annually in the European Union. Manage-ment of AF remains challenging especially with new pharmacological and non-pharmacological approaches becoming readily available. This review article discusses the multitude of therapeutic options and how they may be applied to best effect.

language: English


FULL TEXT  REPRINTS

top of page